New York Blood Center CRS is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Blood Center CRS has participated in 20 clinical trials.
Therapeutic areas: HIV Infections, SARS-CoV-2 Infection, SARS-CoV-2.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network, COVID-19 Prevention Network.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Blood Center CRS has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Blood Center CRS has 20 clinical trials on record. Their work covers HIV Infections, SARS-CoV-2 Infection, SARS-CoV-2.
Yes — New York Blood Center CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.